Document:

Exhibit 10.1

CENTENNIAL
BANK HOLDINGS, INC.

CHANGE IN CONTROL SEVERANCE PLAN

1.             Purpose.  The purpose of the Centennial Bank Holding,
Inc. Change in Control Severance Plan (the “Plan”) is to recruit and foster the continuous employment
of key management personnel of the Company and to reinforce and encourage their
continued attention and dedication to their duties in the event of any threat
or occurrence of a Change in Control (as defined in Section 2), although no
such change is now apparent or contemplated.

2.             Definitions.  As used in this Plan, the following terms
shall have the respective meanings set forth below:

(a)           “Annual Performance Bonus” means the
annual bonus awarded under the Company’s Executive Cash Incentive Plan or
Annual Incentive Plan (or, in each case, any predecessor, substitute or
successor plan designated as such by the Board), as in effect from time to
time.

(b)           “Base Salary” means the Participant’s
annual base salary in effect immediately before the occurrence of the
circumstance giving rise to the Participant’s termination, or, if greater, the
Participant’s annual base salary in effect immediately before the Change in
Control.

(c)           “Board” means the Board of Directors
of the Company and, after a Change in Control, the “board of directors” of the
surviving company.

(d)           “Bonus Amount” means the average of
a Participant’s 2 Annual Performance Bonuses for the 2 fiscal years ending
before the Participant’s Date of Termination; provided that (i) if a
Participant has been an employee of the Company through the end of only one
fiscal year before the Participant’s Date of Termination and was eligible for
an Annual Performance Bonus for such fiscal year (including on a pro rata
basis), the Bonus Amount shall be the average of (x) the Annual Performance
Bonus for the fiscal year ending before the Date of Termination (if such bonus
was made on a pro rata basis, such bonus shall be annualized for the purpose of
calculating the Bonus Amount) and (y) the Participant’s target Annual
Performance Bonus, expressed as a percentage of base salary in the event the
relevant goals are 100% achieved, for the fiscal year in which the Date of
Termination occurs and (ii) if a Participant (x) has been an employee of
the Company through the end of only one fiscal year before the Participant’s
Date of Termination and was not eligible for an Annual Performance Bonus for
such fiscal year or (y) has not been an employee of the Company through
the end of one fiscal year with the Company before the Participant’s Date of
Termination, the Bonus Amount shall be the Participant’s target Annual
Performance Bonus, expressed as a percentage of base salary in the event the
relevant goals are 100% achieved, for the year in which the Date of Termination
occurs.

 

(e)           “Cause” means (i) an intentional and
continued failure of a Participant to perform duties with the Company and its
subsidiaries (for the avoidance of doubt, excluding any failure due to physical
or mental illness) and such failure continues after a written demand for
substantial performance is delivered by the Company to the Participant that
specifically identifies the manner in which the Participant has failed to
perform; (ii) an intentional act of illegal conduct or gross misconduct that is
demonstrably injurious (other than to a de minimis extent) to the business,
reputation or regulatory relationships of the Company; (iii) an intentional act
of fraud, embezzlement or theft in connection with the business of the Company;
(iv) intentional disclosure of confidential information or trade secrets of the
Company or confidential information relating to customers of the Company or its
parent, a subsidiary or affiliate; (v) an act constituting a felony or a
misdemeanor involving moral turpitude for which the Participant is convicted by
any federal, state or local authority, or to which the Participant enters a
plea of guilty or nolo contendere; (vi) an act or omission that causes the
Participant to be disqualified or barred by any governmental or self-regulatory
authority from serving in his or her employment capacity or losing any
governmental or self-regulatory license that is reasonably necessary for the
Participant to perform his or her responsibilities to the Company; or (vii)
intentional breach of corporate fiduciary duty involving personal profit.  For the purposes of this Plan, no act, or
failure to act, on the part of the Participant shall be deemed “intentional”
unless done, or omitted to be done, by the Participant not in good faith and without
reasonable belief that his or her action or omission was in the best interest
of the Company.  Notwithstanding the
foregoing, the Participant shall not be deemed to have been terminated for
Cause hereunder unless and until there shall have been delivered to the
Participant a copy of a resolution duly adopted by the affirmative vote of not
less than two-thirds of the members of the Board then in office at a meeting of
the Board called and held for such purpose (after reasonable notice to the
Participant and an opportunity for the Participant, together with his or her
counsel to be heard before the Board), finding that, in the good faith opinion
of the Board, the Participant had committed an act set forth above in clauses
(i) through (vii) and specifying the particulars thereof in detail.  Nothing herein shall limit the right of the
Participant or his or her beneficiaries to contest the validity or propriety of
any such determination.

(f)            “Change in Control” means the
occurrence of any one of the following events:

(i)            any “Person” or
“Group” (as such terms are defined in Section 13(d) of the Securities Exchange
Act of 1934 (the “Exchange Act”)
and the rules and regulations promulgated thereunder) is or becomes the
“Beneficial Owner” (within the meaning of Rule 13d-3 under the Exchange Act),
directly or indirectly, of securities of the Company, or of any entity
resulting from a merger or consolidation involving the Company, representing
more than 50% of the combined voting power of the then outstanding securities
of the Company or such entity;

 2
 

 

(ii)           the individuals who, as
of the date hereof, are members of the Board (the “Existing Directors”), cease, for any
reason, to constitute more than 50% of the number of authorized directors of
the Company as determined in the manner prescribed in the Company’s Certificate
of Incorporation and Bylaws; provided that if the election, or
nomination for election, by the Company’s stockholders of any new director was
approved by a vote of at least 50% of the Existing Directors, such a new
director shall be considered an Existing Director; provided  further,
that no individual shall be considered an Existing Director if such individual
initially assumed office as a result of either an actual or threatened election
contest (“Election Contest”)
or other actual or threatened solicitation of proxies by or on behalf of anyone
other than the Board (a “Proxy Contest”),
including by reason of any agreement intended to avoid or settle any Election
Contest or Proxy Contest; or

(iii)          the consummation of a
plan of reorganization, merger or consolidation involving the Company or the
sale of all or substantially all of the assets or deposits of the Company,
except for a reorganization, merger, consolidation or sale where (A) the
stockholders of the Company immediately before such reorganization, merger,
consolidation or sale own directly or indirectly at least 55% of the combined
voting power of the outstanding voting securities of the Company resulting from
such reorganization, merger or consolidation or purchasing the assets or deposits
(the “Surviving Company”)
in substantially the same proportion as their ownership of voting securities of
the Company immediately before such reorganization, merger, consolidation or
sale, and (B) the Existing Directors immediately before the execution of
the agreement providing for such reorganization, merger, consolidation or sale
constitute at least half of the members of the board of directors of the
Surviving Company, or of a company beneficially owning, directly or indirectly,
a majority of the voting securities of the Surviving Company (a “Resulting Parent”).

If there is a reorganization, merger,
consolidation or sale of the Company that does not result in a Change in
Control pursuant to clause (iii), references to “the Company” in this definition
will be deemed to have been replaced by references to the Resulting Parent (or
if there is no Resulting Parent, the Surviving Company).

(g)           “Code” means the Internal Revenue Code
of 1986, as amended.

(h)           “Company” means Centennial Bank
Holdings, Inc. and the tax-controlled group of which it is a member.

(i)            “Date of Termination” means (i) if a
Participant’s employment is terminated for Disability, 30 days after notice of
termination is given by the Company (provided that the Participant shall not
have returned to the full-time performance of his or her duties during such 30
day period); (ii) if a Participant’s employment is terminated

 3
 

 

by the Participant, the date specified in the notice of termination,
which shall not be less than 30 days after notice of termination is given
(unless the Company selects an earlier Date of Termination); or (iii) if a
Participant’s employment is terminated for any other reason, the date specified
in the notice of termination.

(j)            “Disability” shall occur if a
Participant is incapacitated and absent from his or her duties on a full-time
basis for 4 consecutive months or for at least 180 days (which need not be
consecutive) during any 12 month period.

(k)           “Good Reason” means, without the
Participant’s express written consent, the occurrence of any of the following
events after a Change in Control:

(i)            the assignment to the
Participant of any duties inconsistent with his or her title, position, duties,
responsibilities and status with the Company as in effect immediately before
the Change in Control, or any other action by the Company that results in a
diminution of the Participant’s title, duties, position or reporting
relationships, or any removal of the Participant from, or any failures to
re-elect the Participant to, any of such positions, except in connection with
the termination of his or her employment for Cause or as a result of his or her
Disability or death, or termination by the Participant other than for Good
Reason; provided that insubstantial or inadvertent actions not taken in
bad faith which are remedied by the Company promptly after receipt of notice
thereof given by the Participant shall not constitute Good Reason;

(ii)           any reduction in the
Participant’s base salary, or a significant reduction in the aggregate employee
benefits provided to the Participant, unless such reduction applies equally to
other similarly situated employees of the Company, in each case, which is not
remedied within 10 calendar days after receipt by the Company of written notice
from the Participant of such change or reduction, as the case may be;

(iii)          the Company requiring
the Participant to be based more than 30 miles from the location of his or her
place of employment immediately before the Change in Control, except for normal
business travel in connection with his or her duties with the Company; or

(iv)          the failure by the
Company to require any successor (whether direct or indirect, by purchase,
merger consolidation or otherwise) to all or substantially all of the business
and/or assets of the Company to expressly assume this Plan and all obligation
hereunder.

An isolated,
insubstantial and inadvertent action taken in good faith implicating clauses
(i), (ii) or (iii) of this definition which is fully corrected by the Company
before the Date of Termination specified in the notice of termination shall not
constitute Good Reason.  A Participant
must provide a notice of termination for Good

 4
 

 

Reason
within 90 days following the Participant’s knowledge of existence of the event
constituting Good Reason or such event shall not constitute Good Reason under
this Plan.

(l)            “Participant” means each of the
employees of the Company who are selected by the Board for coverage by this
Plan and identified on Schedule A.

(m)          “Qualifying Termination” means a termination
of the Participant’s employment (i) by the Company other than for Cause or (ii)
by the Participant for Good Reason. 
Termination of the Participant’s employment with the Company on account
of death, Disability or retirement (in accordance with the normal retirement
policy of the Company as in effect before the Change in Control) shall not be
treated as a Qualifying Termination. 
Notwithstanding the preceding sentence, the death or Disability of the
Participant after notice of termination for Good Reason or without Cause has
been validly provided shall be deemed to be a Qualifying Termination.

(n)           “Severance Multiple” means, for each
Participant, a number determined by the Board in its sole discretion and noted
on Schedule A.

(o)           “Termination Period” means the
period of time beginning with a Change in Control and ending 2 years following
such Change in Control.  Notwithstanding
anything in this Plan to the contrary, if a Participant’s employment with the
Company is terminated before the occurrence of a Change in Control, the
Participant’s employment will be deemed to have been terminated by the Company
without Cause on the day after the occurrence of the Change in Control if (i) a
Change in Control actually occurs, (ii) during the Change in Control Period (as
defined in Section 16(d)) ending on such Change in Control, the Participant’s
employment is terminated by the Company other than for Cause or by the
Participant for Good Reason or (iii) the Participant reasonably demonstrates
that the Company terminated the Participant’s employment, or gave the
Participant Good Reason, at the request of a Person (other than the Company)
who has indicated an intention or taken steps reasonably calculated to effect a
Change in Control, or otherwise in connection with, or in anticipation of, the
Change in Control.  For purposes of
determining the timing of payments and benefits to the Participant under
Section 4, the date of the actual Change in Control shall be treated as
the Participant’s Date of Termination under Section 2(i), and for purposes
of determining the amount of payments and benefits owed to the
Participant under Section 4, the date the Participant’s employment is
actually terminated shall be treated as the Participant’s Date of Termination
under Section 2(i).

3.             Eligibility.  The Board shall determine in its sole
discretion which employees of the Company shall be Participants.  Once an employee becomes a Participant, the
employee shall remain a Participant until the earlier of (1) the expiration of
the Participant’s “participation period” noted on Schedule A and (2) the
Board’s removal of the employee as a Participant in this Plan.  The Board may remove an employee as a
Participant in this Plan at any time in its sole discretion except that a
Participant may not be removed as a Participant without his or her prior
written consent

 5
 

 

either (i) during a
Change in Control Period or Termination Period or (ii) unless the Company
provides Participant with at least 6 months prior notice of such removal. 
For the avoidance of doubt, if a Participant is removed as a Participant in
this Plan pursuant to clause (ii) in the immediately preceding sentence and
during such 6 month notice period a Change in Control Period is triggered
pursuant to which an actual Change in Control occurs, the Participant shall not
be removed or be deemed to have been removed from this Plan.

4.             Payments Upon Termination of Employment.  If during the Termination Period the
employment of the Participant is terminated pursuant to a Qualifying Termination,
then, subject to the Participant’s execution of a Separation Agreement and
Release in the form attached to this Plan as Schedule C (the “Separation Agreement and Release”),
the Company shall provide to the Participant:

(a)           his
or her full base salary through the Date of Termination at the rate in effect
at the time notice of termination is given, plus all other amounts to which he
or she is entitled under any compensation plan of the Company, as the case may
be, in effect immediately before the Change in Control, at the time such
payments are due;

(b)           
within 8 days following the Date of Termination (or, if later, the execution by
the Participant of the Separation Agreement and Release), but in no event
before the date on which such Separation Agreement and Release becomes
effective (including the expiration of any applicable revocation period), a
lump sum cash payment equal to the result of multiplying (i) the Participant’s
current target Annual Performance Bonus, expressed as a percentage of base salary
in the event the relevant goals are 100% achieved, for the year in which the
Date of Termination occurs by (ii) a fraction, (A) the numerator of which is
the number of days elapsed from the beginning of the relevant period for which
performance is measured in determining such Annual Performance Bonus until the
Date of Termination and (B) the denominator of which is the number of days of
such relevant period;

(c)           within
8 days following the Date of Termination (or, if later, the execution by the
Participant of the Separation Agreement and Release), but in no event before
the date on which such Separation Agreement and Release becomes effective
(including the expiration of any applicable revocation period), a lump sum cash
payment equal to the result of multiplying (i) the sum of (A) the
Participant’s Base Salary, plus (B) the Participant’s Bonus Amount by
(ii) the Participant’s Severance Multiple;

(d)           for
the number of years from the Date of Termination equal to the Severance
Multiple, continued provision of medical, dental, and vision benefits to the
Participant, his or her spouse and his or her eligible dependants on the same
basis as such benefits are then currently provided to such Participant (the “Medical Benefits”); provided
that such benefits shall be secondary to any other coverage obtained by the
Participant; provided  further that if the Company’s welfare plans
do not permit such

 6
 

 

coverage, the Company will provide the Participant the Medical Benefits
with the same tax effect; and

(e)           if
the Participant is subject to any excise tax imposed under Section 4999 of the
Code (the “Excise Tax”) by reason of a
Change in Control, then the Company shall pay to the Participant an amount as
specified in Schedule B.

Except as otherwise expressly provided pursuant to this Plan, this Plan
shall be construed and administered in a manner which avoids duplication of
compensation and benefits which may be provided under any other plan, program,
policy, or other arrangement or individual contract.  In the event a Participant is covered by any
other plan, program, policy, individually negotiated agreement or other
arrangement, in effect as of his or her Date of Termination, that may duplicate
the payments and benefits provided for in this Section 4, the Board is specifically
empowered to reduce or eliminate the duplicative benefits provided for under
the Plan.

This Plan does not abrogate any of the usual entitlements which a
Participant has or will have, first, while a regular employee, and
subsequently, after termination, and thus a Participant shall be entitled to
receive all benefits payable to him or her under each and every qualified plan,
welfare plan and any other plan or program relating to benefits and deriving
from his or her employment with the Company, but solely in accordance with the
terms and provisions thereof.

5.             Withholding Taxes.  The Company may withhold from all payments
due to the Participant (or his or her beneficiary or estate) hereunder all
taxes which, by applicable federal, state, local or other law, the Company is
required to withhold therefrom.

6.             Reimbursement of Expenses.  If a Change in Control actually occurs and
any contest or dispute shall arise under this Plan involving termination of a
Participant’s employment with the Company or involving the failure or refusal
of the Company to perform fully in accordance with the terms hereof, the
Company shall reimburse the Participant on a current basis for all reasonable
legal fees and related expenses, if any, incurred by the Participant in connection
with such contest or dispute, provided that the Participant shall be
required to repay immediately any such amounts to the Company to the extent
that a court or an arbitration panel issues a final and non-appealable order
setting forth the determination that the position taken by the Participant was
frivolous or advanced by the Participant in bad faith.

7.             Scope of Plan.  Nothing in this Plan shall be deemed to
entitle the Participant to continued employment with the Company, and if a
Participant’s employment with the Company shall terminate before a Change in
Control, the Participant shall have no further rights under this Plan (except
as specifically provided herein); provided that any termination of a
Participant’s employment during the Termination Period shall be subject to all
of the provisions of this Plan.

 7
 

 

8.             Certain Additional Agreements under Section 409A.  In the event the payment of any amounts under
this Plan would be treated as non-qualified deferred compensation under Section
409A of the Code, such payment will be delayed for 6 months after the Date of
Termination if required in order to avoid additional tax under Section 409A of
the Code.  If a Participant dies within 6
months following such termination of employment, any such delayed payments
shall not be further delayed, and shall be immediately payable to his or her
estate in accordance with the applicable provisions of this Plan.

9.             Participant Covenants.

(a)           In
the performance of the Participant’s duties, the Participant has previously had,
and may in the future have, access to confidential records and information,
including, but not limited to, development, marketing, purchasing,
organizational, strategic, financial, managerial, administrative,
manufacturing, production, distribution and sales information, data,
specifications and processes presently owned or at any time hereafter developed
by the Company or its agents or consultants or used presently or at any time
hereafter in the course of its business, that are not otherwise part of the
public domain (collectively, the “Confidential
Material”).  All such
Confidential Material is considered secret and has been and/or will be
disclosed to the Participants in confidence. 
By executing a Separation Agreement and Release, a Participant shall
agree that:

(i)            the Confidential
Material constitutes propriety information of the Company which draws
independent economic value, actual or potential, from not being generally known
to the public or to other persons who could obtain economic value from its
disclosure or use, and that the Company has taken efforts reasonable under the
circumstances, of which this Section 9(a) is an example, to maintain its
secrecy;

(ii)           except in the
performance of a Participant’s duties to the Company, he or she shall not,
directly or indirectly for any reason whatsoever, disclose or use any such
Confidential Material that (x) has been publicly disclosed or was within the
Participant’s possession before its being furnished to him or her by the
Company or becomes available to him or her on a nonconfidential basis from a
third party (in any of such cases, not due to a breach by the Participant or
his or her obligations to the Company or by breach of any other person of a
confidential, fiduciary or confidential obligation, the breach of which the
Participant knows or reasonably should know), (y) is required to be disclosed
by the Participant pursuant to applicable law, and the Participant provides
notice to the Company of such requirement as promptly as possible, or (z) was independently
acquired or developed by the Participant without violating any of the
obligations under this Plan and without relying on Confidential Material of the
Company; and

 8
 

 

(iii)          All records, files,
drawings, documents, equipment and other tangible items, wherever located,
relating in any way to the Confidential Material or otherwise to the Company’s
business, which a Participant has prepared, used or encountered shall be and
remain the Company’s sole and exclusive property and shall be included in the Confidential
Material, and, upon a Participant’s termination of employment with the Company,
or whenever requested by the Company, he or she shall promptly deliver to the
Company any and all of the Confidential Material and copies thereof, not
previously delivered to the Company, that may be, or at any previous time has
been, in his or her possession or under his or her control.

(b)           By
executing a Separation Agreement and Release, a Participant shall agree that,
for a number of years following his or her Date of Termination equal to the
Severance Multiple, he or she shall not, in any manner, directly or indirectly
(without the prior written consent of the Company):  (i) Solicit any Client to transact business
with a Competitive Enterprise or to reduce or refrain from doing any business
with the Company, (ii) interfere with or damage any relationship between the
Company and a Client or (iii) Solicit anyone who is then an employee of the
Company (or who was an employee of the Company within the prior 12 months) to
resign from the Company or to apply for or accept employment with any other
business or enterprise.  For purposes of
this Plan: (i) “Competitive
Enterprise” means any business enterprise that either
(A) engages in any activity closely associated with commercial banking or
the operation of an institution, the deposits of which are insured by the
Federal Deposit Insurance Corporation, in a Restricted Territory (as defined
below), or (B) holds a 25%
or greater equity, voting or profit participation interest in any enterprise
that engages in such a competitive activity; (ii) “Client”
means any client or prospective client of the Company to whom the Participant
provided services, or for whom the Participant transacted business; and (iii) “Solicit”
means any direct or indirect communication of any kind, regardless of who
initiates it, that in any way invites, advises, encourages or requests any
person to take or refrain from taking any action.  Nothing
in this Section 9(b), however, shall prohibit a Participant or any Person or
entity in which he or she has an interest from placing advertisements in
periodicals of general circulation soliciting applications for employment, or
from employing any person who answers any such advertisement.  A Participant shall not be deemed to violate
this Section 9(b) solely by virtue of his or her interest in a Person whose
stock is publicly traded if he or she is the owner of not more than 2% of the
outstanding shares of any class of stock of such corporation, provided he or she
has no active participation in the business of such corporation (other than
voting his or her stock) and he or she does not provide services to such
corporation in any capacity (whether as an employee, an independent contractor
or consultant, a board member, or otherwise).

(c)           Solely
in the case of a Participant whose Severance Multiple is more than 2, by his or
her executing a Separation Agreement and Release, he or she agrees that, for 2
years following the Date of Termination, he or she shall not directly or

 9
 

 

indirectly (without the prior written consent of the Company) associate
(including as a director, officer, employee, partner, consultant, agent or
advisor) with a Competitive Enterprise in a Restricted Territory and in
connection with such Participant’s association engage, or directly or
indirectly manage or supervise personnel engaged, in any activity:

(i)            that is substantially
related to any activity that the Participant was engaged in with the Company
during the 12 months before the date of termination of the Participant’s
employment,

(ii)           that is substantially
related to any activity for which the Participant had direct or indirect
managerial or supervisory responsibility with the Company during the 12 months
before the Date of Termination, or

(iii)          that calls for the
application of specialized knowledge or skills substantially related to those
used by the Participant in his or her activities with the Company during the 12
months before the Date of Termination.

For purposes
of this Plan, “Restricted Territory”
means the geographic area of all counties in which the Company (or its
subsidiaries) has a branch.  In addition,
for the purposes of this Plan, each Participant whose Severance Multiple is
more than 2 is part of “executive and management personnel” of the Company
within the meaning of C.R.S. § 8-2-113(2).

(d)           By
a Participant’s acceptance of payments under this Plan, he or she shall be
deemed to have acknowledged that violation of Sections 9(a), 9(b) or 9(c) of
this Plan would cause the Company irreparable damage for which the Company
cannot be reasonably compensated in damages in an action at law, and that
therefore, in the event of any breach by him or her of such Sections, the
Company shall be entitled to make application to a court of competent
jurisdiction for equitable relief by way of injunction or otherwise (without
being required to post a bond).  This
provision shall not, however, be construed as a waiver of any of the rights
which the Company may have for damages under this Plan or otherwise, and,
except as limited in Section 13(b), all of the Company’s rights and remedies
shall be unrestricted.

 10
 

 

10.           Successors; Binding Agreement.

(a)           The
Company will require any successor (whether direct or indirect, by purchase,
merger, consolidation or otherwise) to all or substantially all of the business
and/or assets of the Company to unconditionally assume all of the obligations
of the Company hereunder.  Failure of the
Company to obtain such assumption before the effectiveness of any such succession
shall constitute Good Reason hereunder and shall entitle the Participant to
compensation and other benefits from the Company in the same amount and on the
same terms as the Participant would be entitled hereunder if the Participant’s
employment were terminated following a Change in Control by reason of a
Qualifying Termination, except that for purposes of implementing the foregoing,
the date on which any succession becomes effective shall be deemed the Date of
Termination.

(b)           The
benefits provided under this Plan shall inure to the benefit of and be
enforceable by the Participant’s personal or legal representatives, executors,
administrators, successors, heirs, distributees, devisees and legatees.  If the Participant shall die while any
amounts would be payable to the Participant hereunder had the Participant
continued to live, all such amounts, unless otherwise provided herein, shall be
paid in accordance with the terms of this Plan to such person or persons
appointed in writing by the Participant to receive such amounts or, if no
person is so appointed, to the Participant’s estate.

11.           Notice of Termination.  Any purported termination of a Participant’s
employment by the Company, or by a Participant, as the case may be, shall be
communicated by written notice of termination to the other party hereto in
accordance with Section 12 hereof.  For
purposes of this Plan, a “notice of termination” shall mean a notice which
shall indicate the specific termination provision in this Plan relied upon and
shall set forth in reasonable detail the facts and circumstances claimed to
provide a basis for termination of the Participant’s employment under the
provision so indicated.  The failure by
the Participant or the Company to set forth in such notice any fact or circumstance
which contributes to a showing of Good Reason or Cause shall not waive any
right of the Participant or the Company hereunder or preclude the Participant
or the Company from asserting such fact or circumstance in enforcing the
Participant’s or the Company’s rights hereunder.

12.           Notice.  For purposes of this Plan, all notices and
other communications required or permitted hereunder shall be in writing and
shall be deemed to have been duly given when delivered or 5 days after deposit
in the United States mail, certified and return receipt requested, postage
prepaid, addressed as follows:

If to the
Participant:  the address listed as the
Participant’s address in the Company’s personnel files.

 11
 

 

 

 

If to the Company:

 

Centennial Bank Holdings, Inc.

1331 Seventeenth
Street, Suite 300

Denver, Colorado
80202

Attention: General
Counsel

 

or to such other address as either party may have
furnished to the other in writing in accordance herewith, except that notices of
change of address shall be effective only upon receipt.

13.           Full Settlement; Resolution of Disputes.

(a)           The
Company’s obligation to make any payments provided for in this Plan and
otherwise to perform its obligations hereunder shall be in lieu and in full
settlement of all other severance payments to the Participant under any other
severance or employment agreement between the Participant and the Company, and
any severance plan of the Company.  In no
event shall the Participant be obligated to seek other employment or take other
action by way of mitigation of the amounts payable to the Participant under any
of the provisions of this Plan and, except as provided in the Separation
Agreement and Release, such amounts shall not be reduced whether or not the Participant
obtains other employment.

(b)           Any
controversy or claim between the Participant and the Company arising out of or
relating to or concerning this Plan (including the covenants contained in
Section 9) and any dispute regarding the Participant’s employment or the
termination of Participant’s employment or any dispute regarding the
application, interpretation or validity of this Plan (each, an “Employment Matter”) will be finally
settled by arbitration in Denver County, Colorado and administered by the
American Arbitration Association (the “AAA”) under its Commercial Arbitration
Rules then in effect.  In the event of
any conflict between this Plan and the rules of the American Arbitration
Association, the provisions of this Plan shall be determinative.  If the parties are unable to agree upon an
arbitrator, they shall select a single arbitrator from a list of 5 arbitrators
designated by the office of the American Arbitrator Association having
responsibility for Denver County, Colorado, all of whom shall be retired judges
who are actively involved in hearing private cases or members of the National
Academy of Arbitrators, and who, in either event, are residents of such
forum.  If the parties are unable to
agree upon an arbitrator from such list, they shall each strike names
alternatively from the list, with the first to strike being determined by
lot.  After each party has used 2
strikes, the remaining name on the list shall be the arbitrator.  The AAA’s Commercial Arbitration Rules will
be modified in the following ways:  (i)
each arbitrator will agree to treat as confidential evidence and other
information presented to them, (ii) there will be no authority to award
punitive damages, (iii) there will be no authority to amend or modify the terms
of the Plan and (iv) a decision must be rendered within 10 business days of the
parties’ closing statements or submission of post-hearing

 12
 

 

briefs.  A Participant or the Company may bring an
action or special proceeding in a state or federal court of competent jurisdiction
sitting in Denver County, Colorado to enforce any arbitration award under this
Section 13(b).

14.           Survival.  The respective obligations and benefits
afforded to the Company and the Participant as provided in Sections 4 (to the
extent that payments or benefits are owed as a result of a termination of
employment that occurs during the term of this Plan) 5, 6, 9, 10(b) and 13
shall survive the termination of this Plan.

15.           GOVERNING LAW; VALIDITY.  THE INTERPRETATION, CONSTRUCTION AND
PERFORMANCE OF THIS PLAN SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN
ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF COLORADO, WITHOUT REGARD TO
THE PRINCIPLE OF CONFLICTS OF LAWS, AND APPLICABLE FEDERAL LAWS.  THE INVALIDITY OR UNENFORCEABILITY OF ANY
PROVISION OF THIS PLAN SHALL NOT AFFECT THE VALIDITY OR ENFORCEABILITY OF ANY
OTHER PROVISION OF THIS PLAN, WHICH OTHER PROVISIONS SHALL REMAIN IN FULL FORCE
AND EFFECT.

16.           Term; Amendment and Termination.

(a)           This
Plan shall continue in full force and effect until its terms and provisions are
completely carried out except that (i) the Board may terminate this Plan at a
time that is both before a Change in Control and not during a Change in Control
Period and (ii) the Board may terminate this Plan as to future Changes in
Control beginning on the second anniversary of the last Change in Control then
to occur.

(b)           This
Plan may be amended in any respect by the Board so long as the amendment is
made at a time that is both before a Change in Control and not during a Change in
Control Period.  In addition, the Board
may amend this Plan as to future Changes in Control beginning on the second
anniversary of the last Change in Control then to occur.

(c)           For
the avoidance of doubt, during a Change in Control Period or Termination
Period, this Plan shall not be subject to amendment, change, substitution,
deletion, revocation or termination in any respect.

(d)           A
“Change in Control Period”
shall begin on the occurrence of any of (i) the Company (or any Person acting
on the Company’s behalf) conducting negotiations to effect a Change in Control
and (ii) the Company (or any Person acting on its behalf) executing a letter of
intent (whether or not binding) or a definitive agreement to effect a Change in
Control and shall end on the earlier of (A) the date of the occurrence of a
Change in Control and (B) 90 days after both (x) the Company (or any
Person acting

 13
 

 

on the
Company’s behalf) ceases conducting negotiations to effect a Change in Control
and (y) any letter of intent (whether or not binding) or a definitive agreement
to effect a Change in Control has terminated or expired (other than with
respect to provisions relating to confidentiality or other provisions
reasonably determined by the Board to be unrelated to effecting a future Change
in Control).

17.           Interpretation and Administration.  The Plan shall be administered by the
Board.  The Board may delegate any of its
powers under the Plan to a committee thereof. 
Unless otherwise provided in this Plan, actions of the Board or such
committee shall be taken by a majority vote of its members.  All references to the “Board” herein shall be
deemed to be references to such delegate, as appropriate. The Board shall have
the authority (i) to exercise all of the powers granted to it under the Plan,
(ii) to construe, interpret and implement the Plan, (iii) to prescribe, amend
and rescind rules and regulations relating to the Plan, (iv) to make all
determinations necessary or advisable in administration of the Plan and (v) to
correct any defect, supply any omission and reconcile any inconsistency in the
Plan.

18.           Type of Plan.  This Plan is intended to be, and shall be
interpreted as an unfunded employee welfare plan under Section 3(1) of the
Employee Retirement Income Security Act of 1974, as amended (“ERISA”) and
Section 2520.104-24 of the Department of Labor Regulations, maintained
primarily for the purpose of providing employee welfare benefits, to the extent
that it provides welfare benefits, and under Sections 201, 301 and 401 of
ERISA, as a plan that is unfunded and maintained primarily for the purpose of
providing deferred compensation, to the extent that it provides such
compensation, in each case for a select group of management or highly
compensated employees.

19.           Severability.  If a provision of this Plan shall be held
illegal or invalid, the illegality or invalidity shall not affect the remaining
parts of this Plan and this Plan shall be construed and enforced as if the
illegal or invalid provision had not been included.

20.           Nonassignability.  Except as otherwise provided in Section
10(b), benefits under the Plan may not be sold, assigned, transferred, pledged,
anticipated, mortgaged, or otherwise encumbered, transferred, hypothecated, or
conveyed in advance of actual receipt the amounts, if any, payable hereunder,
or any part thereof by the Participant.

21.           Effective Date.  The Plan shall be effective as of December
11, 2006.

 14

 

Schedule
A

	
  Employee

  	
   

  	
  Severance Multiple

  	
   

  	
  Participation Period

  
	
  Daniel M. Quinn

  	
   

  	
  3

  	
   

  	
  Until removed by the Board in accordance with
  Section 3.

  
	
  Zsolt K. Besskó

  	
   

  	
  2

  	
   

  	
  Until removed by the Board in accordance with
  Section 3.

  
	
  Suzanne R. Brennan

  	
   

  	
  2

  	
   

  	
  Until removed by the Board in accordance with
  Section 3.

  
	
  Sherri L. Heronema

  	
   

  	
  2

  	
   

  	
  Until removed by the Board in accordance with
  Section 3.

  
	
  Paul W. Taylor

  	
   

  	
  2

  	
   

  	
  Until removed by the Board in accordance with
  Section 3.

  

 

Schedule
B

Additional Reimbursement
Payments by the Company

(a)           Pursuant to Section 4(e) of the Plan,
in the event it shall be determined that any payment, award, benefit or
distribution (or any acceleration of any payment, award, benefit or
distribution) by the Company (or any of its affiliated entities) or any entity
which effectuates a Change in Control (or any of its affiliated entities) to or
for the benefit of the Participant (whether pursuant to the terms of this Plan
or otherwise, but determined without regard to any additional payments required
under this Schedule B) (the “Payments”)
would be subject to the excise tax imposed by Section 4999 of the Internal
Revenue Code of 1986, as amended (the “Code”),
or any interest or penalties are incurred by the Participant with respect to
such excise tax (such excise tax, together with any such interest and
penalties, are hereinafter collectively referred to as the “Excise Tax”), then the Company shall
pay to the Participant an additional payment (a “Reimbursement Payment”) in an amount such that after
payment by the Participant of all taxes (including any Excise Tax) imposed upon
the Reimbursement Payment, the Participant retains an amount of the
Reimbursement Payment equal to the Excise Tax imposed upon the Payments.  For purposes of determining the amount of the
Reimbursement Payment, the Participant shall be deemed to (i) pay federal
income taxes at the highest marginal rates of federal income taxation for the
calendar year in which the Reimbursement Payment is to be made and
(ii) pay applicable state and local income taxes at the highest marginal
rate of taxation for the calendar year in which the Reimbursement Payment is to
be made, net of the maximum reduction in federal income taxes which could be obtained
from deduction of such state and local taxes.

(b)           Notwithstanding the provisions of
paragraph (a) above, if it shall be determined that the Participant is entitled
to a Reimbursement Payment, but that the Payments would not be subject to the
Excise Tax if the Payments were reduced by an amount that is no more than 10%
of the portion of the Payments that would be treated as “parachute payments”
under Section 280G of the Code, then the amounts payable to the Participant
under this Plan shall be reduced (but not below zero) to the maximum amount
that could be paid to the Participant without giving rise to the Excise Tax
(the “Safe Harbor Cap”),
and no Reimbursement Payment shall be made to the Participant.  The reduction of the amounts payable
hereunder, if applicable, shall be made by reducing first the payments under
Section 4(c) of the Plan, unless an alternative method of reduction is elected
by the Participant.

(c)           Subject to the provisions of
paragraphs (a) and (b) above, all determinations required to be made under this
Schedule B, including whether and when a Reimbursement Payment is
required, the amount of such Reimbursement Payment, the amount of any Option
Redetermination (as defined below), the reduction of the Payments to the Safe
Harbor Cap and the assumptions to be utilized in
arriving at such determinations, shall be made by a public accounting firm that
is retained by the

 

Company
as of the date immediately before the Change in Control (the “Accounting Firm”) which shall provide
detailed supporting calculations both to the Company and the Participant within
15 business days of the receipt of notice from the Company or the Participant
that there has been a Payment, or such earlier time as is requested by the
Company (collectively, the “Determination”).  For the avoidance of doubt, the Accounting
Firm may use the Option Redetermination amount in determining the reduction of
the Payments to the Safe Harbor Cap. 
Notwithstanding the foregoing, in the event (i) the Board shall
determine before the Change in Control that the Accounting Firm is precluded
from performing such services under applicable auditor independence rules or
(ii) the Audit Committee of the Board determines that it does not want the
Accounting Firm to perform such services because of auditor independence
concerns or (iii) the Accounting Firm is serving as accountant or auditor for
the person(s) effecting the Change in Control, the Board shall appoint another
nationally recognized public accounting firm to make the determinations required
hereunder (which accounting firm shall then be referred to as the “Accounting
Firm” for all purposes of this Plan). 
All fees and expenses of the Accounting Firm shall be borne solely by
the Company, and the Company shall enter into any agreement reasonably
requested by the Accounting Firm in connection with the performance of the
services hereunder.  The Reimbursement
Payment under this Schedule B with respect to any Payments shall be made
no later than 30 days following such Payment. 
If the Accounting Firm determines that no Excise Tax is payable by a
Participant, it shall furnish the Participant with a written opinion to such
effect, and to the effect that failure to report the Excise Tax, if any, on the
Participant’s applicable federal income tax return will not result in the
imposition of a negligence or similar penalty. 
In the event the Accounting Firm determines that the Payments shall be
reduced to the Safe Harbor Cap, it shall furnish the Participant with a written
opinion to such effect.  The Determination
by the Accounting Firm shall be binding upon the Company and the Participant.

(d)           As a result of the uncertainty in the
application of Section 4999 of the Code at the time of the Determination, it is
possible that Reimbursement Payments which will not have been made by the
Company should have been made (“Underpayment”)
or Reimbursement Payments are made by the Company which should not have been
made (“Overpayment”),
consistent with the calculations required to be made hereunder.  In the event the amount of the Reimbursement
Payment is less than the amount necessary to reimburse the Participant for the Excise Tax, the Accounting Firm shall determine the amount
of the Underpayment that has occurred and any such Underpayment (together with
interest at the rate provided in Section 1274(b)(2)(B) of the Code) shall be
promptly paid by the Company to or for the benefit of the Participant.  In the event the amount of the Reimbursement
Payment exceeds the amount necessary to reimburse the Participant for the Excise Tax, the Accounting Firm shall determine the amount
of the Overpayment that has been made and any such Overpayment (together with
interest at the rate provided in Section 1274(b)(2) of the

 B-2
 

 

Code)
shall be promptly paid by the Participant (to the extent the Participant has
received a refund if the applicable Excise Tax has been paid to the Internal
Revenue Service) to or for the benefit of the Company.  The Participant shall cooperate, to the
extent his or her expenses are reimbursed by the
Company, with any reasonable requests by the Company in connection with any
contests or disputes with the Internal Revenue Service in connection with the
Excise Tax.  In the event that the
Company makes a Reimbursement Payment to the Participant and subsequently the
Company determines that the value of any accelerated vesting of stock options
held by the Participant shall be redetermined within the context of Treasury
Regulation §1.280G-1 Q/A 33 (the “Option Redetermination”),
the Participant shall (i) file with the Internal Revenue Service an amended
federal income tax return that claims a refund of the overpayment of the Excise
Tax attributable to such Option Redetermination and (ii) promptly pay the
refunded Excise Tax to the Company; provided
that the Company shall pay all reasonable professional fees incurred in the
preparation of the Participant’s amended federal income tax return.  If the Option Redetermination occurs in the
same year that the Reimbursement Payment is included in the Participant’s
taxable income, then in addition to returning the refund to the Company, the
Participant will also promptly return to the Company any tax benefit realized
by the return of such refund and the return of the additional tax benefit
payment (all determinations pursuant to this sentence shall be made by the
Accounting Firm).  In
the event that amounts payable to the Participant under this Plan were reduced
pursuant to paragraph (b) above and subsequently the Participant determines
there has been an Option Redetermination that reduces the value of the Payments
attributable to such options, the Company shall promptly pay to the Participant
any amounts payable under this Plan that were not previously paid solely as a
result of the provisions of paragraph (b) above, up to the Safe Harbor Cap.

 B-3

Schedule C

FORM OF CIC SEPARATION AGREEMENT AND RELEASE
(HEREIN 

“AGREEMENT”)

In connection with the
termination of your employment by Centennial Bank Holdings, Inc. (the “Company”), effective                      ,
200  , and in accordance with the terms and conditions of the
Centennial Bank Holdings, Inc. Change In Control Severance Plan, as established
December 11, 2006 (the “Plan”), the
Company agrees to provide you, contingent upon your execution of this
agreement, with the following severance payment and benefits:

·                  [description of severance payment and
benefits to be inserted]

In consideration of the
payment and benefits set forth above, you agree knowingly and voluntarily as
follows:

1.                                       You knowingly and voluntarily waive and
release forever whatever claims you ever had, now have or hereafter may have
against the Company and any subsidiary or affiliate of the Company, any of
their successors or assigns and any of their present and former employees,
directors, officers and agents (collectively referred to as “Releasees”), based
upon any matter, occurrence or event existing or occurring before the execution
of this agreement, including anything relating to your employment with the
Company and any of its subsidiaries or affiliates or to the termination of such
employment or to your status as a shareholder or creditor of the Company.

This release and waiver includes but is not limited to any rights or
claims under United States federal, state or local law and the national or local law of any foreign
country (statutory or decisional), for wrongful or abusive discharge, for
breach of any contract, for misrepresentation, for breach of any securities
laws, or for discrimination based upon race, color, ethnicity, sex, age,
national origin, religion, disability, sexual orientation, or any other
unlawful criterion or circumstance, including rights or claims under the Age
Discrimination in Employment Act of 1967 (“ADEA”)(except that you do not waive
ADEA rights or claims that may arise after the date of this agreement).

2.                                       You agree never to institute any claim, suit
or action at law or in equity against any Releasee in any way by reason of any
claim you ever had, now have or hereafter may have relating to the matters
described in the two preceding paragraphs.

3.                                       The payment and benefits described herein
shall be in lieu of any and all other amounts to which you might be, are now or
may become entitled from the Company, its subsidiaries and affiliates and,
without limiting the generality of the foregoing, you hereby expressly waive
any right or claim that you may have or assert to payment for salary, bonuses,
medical, dental or hospitalization benefits, life insurance benefits or
attorneys’ fees; provided that notwithstanding any other provision of
this agreement, you do not waive any of your rights and the

 

Company shall comply with its obligations with respect to continuation
coverage requirements under Section 4980B of the Internal Revenue Code of 1986,
as amended (commonly referred to as “COBRA”).

4.                                       You hereby expressly agree to comply with the
restrictions on your conduct set forth in Section 9 of the Plan for the periods
applicable to you (as if such Section 9 were directly incorporated in this
Agreement).  You acknowledge that your
compliance with Section 9 of the Plan is a material condition to the Company
providing you with the payment and benefits described herein and that the
Company would not have agreed to provide such payment or benefits absent your
agreement.  You also acknowledge that
Section 9 of the Plan limits your ability to earn a livelihood in a Competitive
Enterprise (as defined in the Plan) and your relationships with Clients (as
defined in the Plan).  You acknowledge,
however, that complying with Section 9 of the Plan will not result in severe
economic hardship for you or your family.

[Your signature below will also constitute
confirmation that (i) you have been given at least 21 days within which to
consider this release and its consequences, (ii) you have been advised before
signing this agreement to consult, and have consulted, with an attorney of your
choice, and (iii) you have been advised that you may revoke this agreement at
any time during the 7 day period immediately following the date you signed this
letter.][Subject to revision based on circumstances of
participant, and in accordance with applicable law]

This agreement shall be
governed by the laws of State of Colorado.

Please confirm by returning
to                            
the enclosed copy of this agreement, signed in the place provided, that you
have knowingly and voluntarily decided to accept and agree to the foregoing.

	
  

  	
  CENTENNIAL BANK
  HOLDINGS, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  Name:

  
	
   

  	
  Title:

  
	
   

  	
   

  

 

 

	
  AGREED AND
  ACKNOWLEDGED:

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Name:

  	
   

  
	
  Date:

  	
   

  
	
   

  	
   

  
			

 

 C-2EXHIBIT
10.36

SECOND
ASSET PURCHASE AGREEMENT

THIS
SECOND ASSET PURCHASE AGREEMENT (this “Agreement”) is entered
into as of the 21st day of November, 2006, by and between FORGENT
NETWORKS, INC., a corporation organized and existing under the laws
of the State of Delaware, U.S.A. (the “Seller”), and TANDBERG
TELECOM AS, a corporation organized and existing under the laws of
the Kingdom of Norway (the “Buyer”).

RECITALS

WHEREAS,
the Seller owns certain “Patents” (as this term is hereinafter defined) related
to video conferencing, video compression, streaming video, scheduling and media
management; and

WHEREAS,
the Buyer desires to purchase such Patents from Seller, and the Seller desires
to sell and transfer to the Buyer such Patents, all as more fully set forth
below; and

WHEREAS,
the Buyer desires to have certain assurances and to continue and reconfirm a
covenant of non-assertion from Seller with regard to “Other Patents” (as
hereinafter defined) owned or controlled by Seller.

NOW,
THEREFORE, in consideration of the foregoing recitals and the
mutual agreements and covenants contained herein, and for other good and
valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the Buyer and the Seller hereby agree as follows:

ARTICLE 1 - PURCHASE AND SALE OF
ASSETS

1.1   Defined
Terms.  Capitalized terms used herein
have the meanings set forth in Article 12.1.

1.2   Purchased Assets. 
Subject to the terms and conditions of this Agreement, and in reliance
upon the representations, warranties, covenants and agreements made in this
Agreement by the Seller and the Buyer, the Buyer shall purchase, accept and
acquire from the Seller, and the Seller shall sell, transfer, convey, assign
and deliver to the Buyer all of Seller’s right, title and interest in and
to:  (i) the Patents, all goodwill
associated directly with the Patents and all rights thereunder, (ii) all
supporting documentation for the Patents and including relevant portions of
laboratory notebooks, invention disclosure forms, patent prosecution files, and
correspondence, opinions of counsel, and similar documents (“Documentation”),
(iii) remedies if any against past, present and future infringements thereof,
and (iv) rights to protection of interests therein under the laws of all
jurisdictions (collectively, the “Purchased Assets”).

1.3   Closing.  The closing (the “Closing”) of the purchase
and sale of the Purchased Assets shall take place at 10 a.m., local time, on
the Closing Date, at the offices of Oblon, Spivak, McClelland, Maier &
Neustadt, P.C., 1940 Duke Street, Alexandria, Virginia 22314.  The “Closing Date” means the date on which
the Closing occurs, anticipated to be Friday, November 24, 2006.

ARTICLE 2 - PURCHASE PRICE

In consideration
of (i) the transfer, sale and assignment of the Purchased Assets and (ii) the
reaffirmation of the covenant of non-assertion contained in Article 6.9, Buyer
agrees to pay Seller the sum of THREE MILLION ONE HUNDRED AND FIFTY THOUSAND
U.S. DOLLARS ($3,150,000.00) (the “Purchase Price”). TWO MILLION NINE HUNDRED
THOUSAND DOLLARS ($2,900,000.00) of the Purchase Price shall be paid to Seller
at Closing by wire transfer in immediately available funds to an account
designated by Seller in writing at or prior to the Closing.  The balance of TWO HUNDRED FIFTY THOUSAND
DOLLARS ($250,000.00) shall constitute a deferred payment to be paid on the
second anniversary of the Closing Date, provided that as of that date no claim
in opposition to Buyer’s ownership of the Patents or the Purchased Assets has
been made and remains uncured and further provided that no transaction has
occurred pursuant to which any entity has secured a license or other rights to
any of the Patents after the Closing Date, other than from Buyer itself.

 

ARTICLE 3 – NON-ASSUMPTION OF
LIABILITIES

Except as set
forth on Schedule 3, the Buyer shall not be responsible for, assume, pay,
perform, discharge, or accept any liabilities, debts, contractual obligations
or other obligations of the Seller of any kind whatsoever, whether actual,
contingent, accrued, known or unknown, including, without limitation, any
relating to interest and termination penalties on indebtedness, taxes, breach
or negligent performance of any contract, liabilities resulting from breach of
contract, illegal activity, unlawful business practice, infringement of
intellectual property rights, any liabilities, obligations or commitments by
Seller relating to or arising out of the ownership of the Purchased Assets
prior to the Closing, or the transfer of the Purchased Assets or any other
liability or obligation of the Seller whatsoever.  All such non-assumed liabilities, debts and
obligations shall remain the responsibility of the Seller.

ARTICLE 4 - REPRESENTATIONS AND
WARRANTIES OF THE SELLER

In order to induce
the Buyer to enter into this Agreement, the Seller makes the following
representations and warranties to the Buyer, each of which shall be deemed to
be independently made and relied upon by the Buyer, regardless of any
investigation made by, or information known to, the Buyer:

4.1      Ownership, Organization and
Qualification.  The Seller is a
corporation duly incorporated and validly existing and in good standing under
the laws of the State of Delaware, has not filed articles of dissolution and
has a perpetual period of existence.  The
Seller has all requisite corporate power and authority to own, operate and
lease its properties and to conduct its business as now being conducted.

4.2      Authorization.  The Seller has obtained the approval from its
Board of Directors and, if necessary, its shareholders to enter into this
Agreement and has all necessary power and authority to enter into this
Agreement.  Seller shall have all
necessary power and authority to perform the transactions contemplated hereby
in accordance with the terms and conditions hereof.

4.3      Enforceability.  This Agreement and all other agreements of
the Seller contemplated hereby are or, upon the execution and delivery thereof
will be, the valid and binding obligations of the Seller, enforceable against
it in accordance with their terms, subject to any limitation of enforceability
that may be imposed by applicable bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium or other similar laws affecting creditor’s
rights and remedies generally and by the application by a court of equitable
jurisdiction (whether such enforceability is considered a proceeding in equity
or in law).

4.4      Conflicting Obligations.  The execution and delivery of this Agreement
does not, and the consummation of the sale and purchase of the Purchased Assets
contemplated hereby will not: (a) conflict with or result in a material
violation of any provisions of the articles or certificate of incorporation or
bylaws of the Seller, as amended and in effect on and as of the date hereof and
on and as of the Closing Date; (b) conflict with or result in a material
violation of any provisions of, or result in the maturation or acceleration of,
any obligations under any contract, agreement, instrument, document, lease,
license, permit, indenture, or obligation, or any law, statute, ordinance,
rule, regulation, code, guideline, order, arbitration award, judgment or
decree, to which the Seller is subject or to which the Seller is a party; or
(c) conflict with, result in a material breach of, constitute a default under,
result in the acceleration of, create in any party the right to accelerate,
terminate, modify, or cancel, or require any notice under any agreement,
contract, lease, license, instrument or other arrangement to which the Seller
is a party or by which it is bound or to which any of the Purchased Assets are
subject (or result in the imposition of any Lien upon any of the Purchased
Assets).

4.5      Title to Assets; Sufficiency.  Except as set forth in Schedule 4.5, the
Seller has good and marketable title to all of the Purchased Assets, free and
clear of any Lien, encumbrance, claim or restriction on transfer and the Patent
Assignment contemplated by this Agreement is sufficient to transfer good and
marketable title of  the Purchased Assets
to Buyer, free and clear of all Liens. 
The Purchased Assets include but are not limited to all of the Patents
owned or controlled by Seller that are set forth in Article 4.7.1 and the
Documentation.

4.6      Third Party Consents.  Except as set forth on Schedule 4.6, no
material third party consents, approvals or authorizations are necessary for
the execution and consummation of the transactions contemplated hereby, nor are
any such consents, approvals or authorizations required in order for any of the
Purchased Assets to be assigned to the Buyer. Seller has full power and
authority to uphold and enforce the covenant of non-assertion set forth in
Article 6.9 hereof without the consent of any other party.

 

4.7      Purchased Assets.

4.7.1            Schedule 4.7.1.1 identifies each
Patent that has been issued to or is owned or controlled by the Seller which is
to be transferred to Buyer and Schedule 4.7.1.2 identifies each pending patent
application or application for registration which the Seller has made, the
rights to which are to be transferred to Buyer. 
Seller has made available to the Buyer correct and complete copies of
all of the Patents.

4.7.2            To the Seller’s Knowledge, the
Seller has taken all actions that are necessary or reasonably appropriate to
maintain and to protect each of the Patents, including, but not limited to
payment of any and all issuance fees, maintenance fees and annuities.

4.7.3            With respect to each of the Patents:
(i) they are not subject to any outstanding injunction, judgment, order,
decree, ruling, or charge; (ii) no action, suit, opposition or  reexamination proceeding, hearing,
investigation, charge, complaint,  claim,
or demand is pending or, to the Seller’s Knowledge, is threatened which
challenges the legality, validity, enforceability, use, or ownership of the
Patent; (iii) no person has notified the Seller of any claim concerning any
alleged interference, infringement, misappropriation, reexamination, opposition
or other conflict of any of the Patents with the intellectual property of any
third party.

4.7.4            The Seller has no Knowledge of any
state of facts or contemplated event that may give rise to any claim, action,
suit, proceeding, complaint, investigation or inspection which could have a
materially adverse effect on the ownership, validity, enforceability or
reasonably anticipated use of the Purchased Assets.

4.7.5            The Seller has no Knowledge of any
products, inventions or procedures of competitors which infringe or
misappropriate any Patent and has not given any notice of infringement, sent
any demand to “cease and desist”, or offered to license any Patent to any third
party based on any claim in the Patents except as set forth in Schedule 4.7.5.

4.7.6            The Patents and the Other Patents
together encompass all patents and patent applications in and related to the
Field which are owned or controlled by Seller and its Affiliates.

4.7.7            To the Seller’s Knowledge, the
Seller and Seller’s patent counsel have complied with the duty of candor in
prosecution of each of the Patents before the United States Patent and
Trademark Office.

4.8      No
Sale, Transfer or License.  Except
for licenses and encumbrances listed in Schedule 4.8, (a) the Seller has not
sold, leased, transferred, or assigned any interest in any of the Purchased
Assets; (b) the Seller has not imposed or permitted any third party to impose
any Lien, not subsequently released, upon any of the Purchased Assets; (c) the
Seller has not granted any option, license or sublicense of any rights under or
with respect to any of the Patents; and (d) the Seller has not committed to any
of the foregoing.  

4.8.1        The
Seller warrants that the pre-existing license(s) of the ‘667 and ‘754 patents
to Polycom is not transferable and not assignable by Seller.  The Seller warrants that the license of the ‘667
and ‘754 patents to Polycom includes no encumbrances on a successor-in-interest
to Seller relative to the patents and applications identified in Schedule
4.7.1.1 and 4.7.1.2.

4.8.2        The
Seller warrants that the “Large Computer Manufacturer” granted a Covenant not
to Assert (CNA) by Seller prior to this Agreement is not a “Competing Company”
which shall be defined as Polycom, Avistar, Starbak, Cisco, Radvision or
another prominent developer or supplier of video teleconferencing equipment to
the U.S. market.  The Seller warrants
that the CNA expires in July 2008.  The
Seller agrees to notify “Large Computer Manufacturer” of Buyer’s purchase
within 30 days of the closing of this agreement, and to invite “Large Computer
Manufacturer” to contact Buyer.  The
Seller warrants that the CNA to the “Large Computer Manufacturer” includes no
encumbrances on a successor-in-interest to Seller relative to the patents and
applications identified in Schedule 4.7.1.1 and 4.7.1.2.

4.8.3        The
Seller warrants that the pre-existing license(s) of the patents and
applications listed in Schedule 4.8 to VTEL Products Corporation is
transferable either in conjunction with a sale of substantially all of VTEL
Products Corporation’s assets or with Seller’s permission.  In the event of a contemplated transfer of
licenses in conjunction of a sale of substantially all assets, the Seller will
make reasonable efforts to exercise its consent for the transfer of the
licenses in a manner to prevent the transfer of the licenses to a Competing
Company.  In the event of a contemplated
transfer of licenses that is not in conjunction with a sale of substantially
all assets, the Seller will

 

exercise its
consent for the transfer of the licenses in a manner to prevent the transfer of
the licenses to a Competing Company.  Seller
warrants that in either of the above cases, Seller and all
successors-in-interest will not agree to a transfer of the license(s) now
granted to VTEL Products Corporation without first providing immediate notice
of a request to transfer and obtaining a written concurrence from Buyer or
Buyer’s successor-in-interest.  The
Seller warrants that the license(s) to VTEL Products Group includes no
additional encumbrances on a successor-in-interest to Seller relative to the
patents and applications identified in Schedule 4.7.1.1 and 4.7.1.2.

4.9      Authority
to Grant Covenant.  Seller has full
power and authority to grant the covenant of non-assertion contained in Article
6.9 hereof and no other person or entity has any right to bring a claim of
infringement pursuant to one or more of the Other Patents as defined herein.

4.10    Brokerage.  The Seller has neither incurred nor made
commitments for, any brokerage, finders or similar fee in connection with the
transaction contemplated by this Agreement.

4.11    Bankruptcy.  The Seller has not filed a petition for
relief under the United States Bankruptcy Code or under any state insolvency
statute nor has it consulted with any counsel or advisor in anticipation of or
to consider the filing of any petition in bankruptcy, moratorium, receivership
or any similar state or federal law.

4.12    No Bulk Sales Laws. No “bulk sales”
laws are applicable to the acquisition of the Purchased Assets or any
transactions contemplated by this Agreement.

4.13    Warranty. EXCEPT AS SPECIFICALLY AND EXPLICITLY
PROVIDED HEREIN (INCLUDING, WITHOUT LIMITATION, IN ARTICLES 4.5, 4.6, 4.7 AND
4.8 ABOVE), THE PURCHASED ASSETS ARE BEING SOLD “AS IS” WITHOUT ADDITIONAL
WARRANTY.

4.14    Representations and Warranties True and
Correct.  The representations and warranties
contained herein, and all other documents, certifications, materials and
statements or information given to the Buyer by or on behalf of the Seller or
disclosed in this Agreement, do not include any untrue statement of a material
fact to Seller’s Knowledge or omit to state a material fact, to the Knowledge
of Seller, required to be stated herein or therein in order to make the
statements herein or therein, in light of the circumstances under which they
are made, not misleading.

ARTICLE 5 - REPRESENTATIONS OF
THE BUYER

In order to induce
the Seller to enter into this Agreement, the Buyer makes the following
representations and warranties to the Seller, each of which shall be deemed to
be independently made and relied upon by the Seller, regardless of any
investigation made by, or information known to, the Seller.

5.1      Ownership, Organization and
Qualification.  The Buyer is a
corporation duly incorporated and validly existing under the laws of the
Kingdom of Norway, has not filed articles of dissolution and has a perpetual
period of existence.  Buyer has all
requisite corporate power and authority to own, operate and lease its
properties and conduct its business as now being conducted.

5.2      Authorization.  The Buyer has all necessary power and
authority to enter into and perform the transactions contemplated hereby in
accordance with the terms and conditions hereof.

5.3      Enforceability.  This Agreement and all other agreements of
the Buyer contemplated hereby are or, upon the execution thereof, will be the valid
and binding obligations of the Buyer enforceable against it in accordance with
their terms, subject to any limitation of enforceability that may be imposed by
applicable bankruptcy, insolvency, fraudulent conveyance, reorganization,
moratorium or other similar laws affecting creditor’s rights and remedies
generally and by the application by a court of equitable jurisdiction (whether
such enforceability is considered a proceeding in equity or in law).

5.4      Conflicting Obligations.  The execution and delivery of this Agreement
do not, and the consummation of the sale and purchase of the Purchased Assets
contemplated hereby will not: (a) conflict with or result in a material
violation of any provisions of the certificate of formation of the Buyer; (b)
conflict with or result in a material violation of any provisions of, or result
in the maturation or acceleration of, any obligations under any contract,
agreement, instrument, document, lease, license, permit, indenture, or
obligation, or any law, statute,

 

ordinance, rule,
regulation, code, guideline, order, arbitration award, judgment or decree, to
which the Buyer is subject to or which the Buyer is a party; or (c) conflict
with, result in a material breach of, constitute a default under, result in the
acceleration of, create in any party the right to accelerate, terminate,
modify, or cancel, or require any notice under any agreement, contract, lease,
license, instrument or other arrangement to which the Buyer is a party or by
which it is bound or to which any of its assets is subject.

5.5      Brokerage.  The Buyer has neither incurred, nor made
commitment for, any brokerage, finders or similar fee in connection with the
transactions contemplated by this Agreement.

5.6      Present Knowledge.  As of the Closing Date, Buyer has no
Knowledge of any actions by, or products held by Seller, which infringe or
misappropriate any intellectual property embodied in the Purchased Assets and
has no present intention of making any action, claim, suit, proceeding,
complaint, investigation or inspection regarding such against or with respect
to Seller.

ARTICLE 6 - COVENANTS OF THE
SELLER

The Seller
covenants and agrees with the Buyer as follows:

6.1      Maintenance of Property.  From the date hereof and until the Closing
Date, the Seller, upon notice to Buyer, shall take all actions necessary or
reasonably appropriate to maintain its right, title and interest in and to the
Purchased Assets.  Furthermore, to the
extent any of the Purchased Assets are registered or held in the name of an
Affiliate of Seller or other person, Seller shall take such actions as are
necessary to ensure such Purchased Assets are effectively assigned to Buyer on
the Closing Date.  The Seller shall pay
all costs related to the same. 
Commencing immediately, Seller and its agents shall refrain from any
activity to sell, license, sublicense, assign, hypothecate, alienate, encumber,
pledge or otherwise transfer any of Seller’s interest in or to any portion of
the Patents.

6.2      Access.  Between the date of this Agreement and the
Closing Date, Seller will, and will instruct its agents and representatives to
give Buyer and its employees, agents or representatives access to the
Documentation and permit Buyer to make reasonable inspection and copies
thereof.  Further, Seller shall instruct
its prosecuting patent counsel or patent agent in each country where the
Patents are issued or pending to reasonably cooperate with Buyer and its
employees, agents or representatives to enable and assist such persons in
understanding the prosecution history of the Patents and to facilitate the
continuing prosecution of the any pending Patents following Closing. All such
access and inspections will be conducted during Seller’s (or its patent counsel’s
or patent agent’s, as applicable) normal business hours and in a manner that
does not unreasonably interfere with the conduct of Seller’s (or its patent
counsel’s or patent agent’s) business.

6.3      Compliance with Laws.  From the date hereof and until the Closing
Date, the Seller shall comply with all applicable laws, statutes, ordinances,
rules, regulations, guidelines, orders, arbitration awards, judgments and
decrees applicable to, or binding upon, the Seller if the breach of any of the
foregoing could reasonably be expected to have a materially adverse effect on
the Purchased Assets.

6.4      Supplemental Disclosure.  Promptly after it becomes aware of such
information and in any event not later than the Closing Date, the Seller shall
inform the Buyer in writing of all material information, events or actions
which, if this Agreement were signed on the Closing Date, would be required to
be disclosed on the Schedules in order to make the Seller’s representations and
warranties contained herein true and not misleading.  The delivery thereof by the Seller shall not
absolve the Seller from liability for breach of any representation or warranty
which was untrue when made.

6.5      Documents of Transfer.  On the Closing Date, the Seller shall duly
execute and deliver to the Buyer:

6.5.1            the
Bill of Sale as described in Exhibit 6.5.1;

6.5.2            the
Patent Assignment as set forth in Exhibit 6.5.2;

6.5.3            All such other assignments, if any,
that shall be required to transfer title to the Buyer pursuant to the terms as
set forth herein.

6.6       Other Deliveries.  On the Closing Date, the Seller shall deliver
to the Buyer the following:

 

6.6.1    A certificate from an officer of Seller
whose responsibilities include maintenance of the Seller’s patent portfolio
substantially in the form of Schedule 6.6.1.

6.6.2    Evidence satisfactory to Buyer’s Counsel
that the Board of Directors of Seller has approved the transaction contemplated
by this Agreement;

6.6.3            A certificate from the Corporate
Secretary of Seller certifying that any necessary approvals from the
shareholders of the Seller have been obtained;

6.6.4            A certificate from an officer of
Seller as described in Articles 8.1 and 8.2 below;

6.6.5            All Documentation in Seller’s
possession or control (in each instance through transmission via computer to
the extent possible) together with a detailed description of any Documentation
which, to Sellers Knowledge, is in existence but which Seller has not delivered
to Buyer; and

6.6.6            All other documents reasonably
requested by counsel for the Buyer to consummate the transactions herein
contemplated.

6.6.7            Within thirty (30) days after
Closing, Seller shall transfer all files and Documentation relating to the
Patents to the offices of Oblon, Spivak, McClelland, Maier & Neustadt, PC,
1940 Duke St., Alexandria, VA, 22314. 
Seller shall maintain all patent and patent application files pending
until such transfer is completed.

 

6.7       Further
Assurances.  The Seller, upon request
of the Buyer, shall execute, acknowledge and deliver such other instruments as
reasonably may be requested to more effectively transfer and vest in the Buyer
the Purchased Assets pursuant to the terms of this Agreement or to otherwise
carry out the terms and conditions of this Agreement.

6.8       Confidentiality.  Information embodied in the Purchased Assets
and the Documentation include confidential information that Seller shall hold
confidential for a period of five (5) years from the date of this Agreement
except (a) information that is or becomes publicly available at the time of
disclosure (through no act of the Seller or any of its Affiliates in violation
of this Article 6.8); (b) information that is disclosed to Seller or any of its
Affiliates by a third party that to the knowledge of Seller or its Affiliates,
after due inquiry, did not disclose in violation of a duty of confidentiality;  (c) disclosures that are required to be made
by Seller under any applicable laws or regulations; or (d) information that is
independently developed, as demonstrated by Seller’s written records.

6.9       Covenant
not to Assert.  In a prior agreement
between the Parties entered into in November 2004 and subsequently amended (the
“Prior Agreement”), Seller agreed and covenanted that it will not assert
against Buyer or its Affiliates or, solely in connection with their
relationship with Buyer and within the Field, their respective contract
manufacturers, distributors, resellers or customers (the “Covered Parties”),
the violation or infringement of any Relevant Rights related to (i) the Patents
listed on Schedule 4.7.1 of the Prior Agreement or (ii) the Other Patents
listed on Schedule 6.9 of the Prior Agreement. In the event that Buyer delivers
or resells products that Buyer and Seller agree fall within the scope of any
claims of Other Patents in this Agreement, Buyer shall make a good faith effort
to mark those products according the marking requirements of the United States
patents statutes.  Buyer and Seller hereby agree and affirm that the
foregoing clarifies the intent of the Prior Agreement.  Seller also agreed and covenanted that in the
event Seller seeks to sell, assign, transfer or license any of its Relevant
Rights to a third party after the Closing, pursuant to which transaction such
third party would acquire a right to claim that any of the Covered Parties is
infringing such Relevant Rights, Seller shall (i) notify Buyer of such proposed
transaction and (ii) shall obtain the written undertaking by such third party
to abide by the terms of this covenant. 
These agreements and covenants are hereby reaffirmed by Seller and
nothing in this Agreement shall be in derogation or constitute a rescission of
such agreements and covenants.

6.9.1  Schedule 6.9.1 contains a release of all
claims by Seller against the Covered Parties, through and including the Closing
Date.

6.10       License.  To the extent that Seller owns any Additional
Patents having one or more claims overlapping in scope with any claim of the
Patents (“Claim Scope Overlap”), Seller hereby grants, and agrees to cause its
appropriate Affiliates to grant, to Buyer and its Affiliates with effect from
the Closing Date a personal,

 

irrevocable,
non-exclusive, worldwide, fully paid-up and royalty free non-assignable and
non-transferable license, to use any and all Additional Patents, limited in
scope to the extent that there is such Claim Scope Overlap.

ARTICLE 7 - COVENANTS OF THE
BUYER

7.1      The Buyer covenants and agrees with the
Seller that on the Closing Date, the Buyer shall deliver to Seller:

7.1.1    The
Purchase Price in accordance with the terms set forth in Article 2 above;

7.2      Subject to Article 14.12, Buyer shall hold
confidential until the longer of the Closing Date, or a date five (5) years
from the date of the execution of this Agreement if no closing has occurred,
any information regarding any of the Purchased Assets except (a) information
that is or becomes publicly
available at the time of disclosure (through no act of the Buyer or any of its
Affiliates in violation of this Article 7.2); (b) information that is disclosed
to Buyer or any of its Affiliates by a third party that to the knowledge of
Buyer or its Affiliates, after due inquiry, did not disclose in violation of a
duty of confidentiality; (c) disclosures that are required to be made by Buyer
under any applicable laws or regulations; or (d) information that is
independently developed, as demonstrated by Buyer’s written records.

ARTICLE 8 - CONDITIONS OF THE
BUYER’S OBLIGATION TO CLOSE

The obligation of
the Buyer to consummate the transactions contemplated by this Agreement shall
be subject to the satisfaction and fulfillment, prior to and on the Closing
Date, of the following express conditions precedent:

8.1      Representation and Warranties.  The representations and warranties in this
Agreement made by the Seller shall be true and correct in all material respects
as of and at the Closing Date with the same force and effect as though said
representations and warranties had been again made on the Closing Date, and the
Buyer shall have been furnished a certificate signed by the President of the
Seller to that effect.

8.2      Performance of Covenants and Obligations.  The Seller shall have performed and complied
in all material respects with all of its covenants and obligations under this
Agreement which are to be performed or complied with by it prior to or on the
Closing Date, and the Buyer shall have been furnished a certificate signed by
an officer of the Seller to that effect.

8.3      Proceedings and Instruments
Satisfactory.  All proceedings,
corporate or otherwise, to be taken in connection with the transactions
contemplated by this Agreement, and all documents incident thereto, shall be
reasonably satisfactory in form and substance to the Buyer.  The Seller shall have made available to the
Buyer, either directly or through its patent counsel, for examination the originals
or true and correct copies of all documents which the Buyer reasonably may
request in connection with the transactions contemplated by this Agreement.

8.4      Adverse Change.  From and after the date of this Agreement and
until the Closing Date, the Buyer (in its reasonable discretion) shall have
determined that there has been no material adverse change in the Purchased
Assets from that disclosed to the Buyer in or under this Agreement.

8.5      No Litigation.  No investigation, suit, action or other
proceeding shall be threatened or pending before any court or governmental
agency in which it is sought to restrain, prohibit or obtain damages or other
relief in connection with this Agreement or the consummation of the
transactions contemplated hereby.

8.6      Consents, Approvals, Certifications,
Licenses and Permits.  All necessary
consents, approvals, certifications, licenses and permits with respect to the
transaction contemplated hereby shall have been received by the Buyer on or
before the Closing Date.

8.7      Assignments.  Seller shall have prepared and delivered to
Buyer all documents necessary or appropriate to transfer and assign to Buyer
title to the Purchased Assets, including any foreign counterparts to the
Patents.

 

ARTICLE 9 - CONDITIONS TO THE
SELLER’S OBLIGATION TO CLOSE

The obligation of
the Seller to consummate the transactions contemplated by this Agreement shall
be subject to the satisfaction and fulfillment, prior to and on the Closing
Date, of the following express conditions precedent:

9.1          Representations
and Warranties.  The representations
and warranties in this Agreement made by the Buyer shall be true and correct in
all material respects as of and at the Closing Date with the same force and
effect as though said representations and warranties had been again made on the
Closing Date.

9.2           Performance of Covenants and
Obligations.  The Buyer shall have
performed and complied with all of its covenants and obligations under this
Agreement which are to be performed or complied with by it prior to or on the
Closing Date.

9.3           No Litigation.  No investigation, suit, action or other
proceeding shall be threatened or pending before any court or governmental
agency in which it is sought to restrain, prohibit or obtain damages or other
relief in connection with this Agreement or the consummation of the
transactions contemplated hereby.

ARTICLE 10 - INDEMNIFICATION BY
SELLER

10.1 Indemnification.  Notwithstanding the Closing, and regardless
of any investigation made by or on behalf of the Buyer or any information known
to the Buyer; the Seller (the “Seller” or “Indemnifying Party”, for purposes of
Articles 10.2 and 10.3) subject to the terms and conditions of this Article 10,
indemnifies and saves the Buyer, its shareholders, officers, directors and/or
employees (collectively, the “Buyer” or “Indemnified Party” for purposes of
Articles 10.2 and 10.3 as used in this Article 10) harmless from and against
any and all losses, claims, damages, actions, liabilities, costs, expenses or
deficiencies including, but not limited to, reasonable attorneys’ fees and
other costs and expenses reasonably incident to proceedings or investigations
or the defense or settlement of any claim or claims, incurred by or asserted
against the Buyer or the Purchased Assets due to or resulting from any of the
following: (a) the inaccuracy or breach of any representation or warranty of
the Seller given in or pursuant to this Agreement; (b) any breach or default in
the performance by the Seller of any of its covenants, obligations or
agreements in or pursuant to this Agreement; (c) any liability or obligation of
the Seller not expressly assumed by the Buyer pursuant to this Agreement;
(d) the ownership or use of the Purchased Assets at any time prior to the
Closing, or any incident, occurrence, condition or claim existing, arising or accruing
prior to the Closing and relating to the ownership or use by Seller or its
Affiliates, or any other person, of the Purchased Assets; or (e) breach of
Seller’s Confidentiality obligations in sections 6.8 and 13.2.  The foregoing are collectively referred to as
“Indemnifiable Damages.”

10.2     Procedure For Indemnification with
Respect to Non-Third Party Claims. In the event that the Indemnified Party
asserts a claim (a “Notice of Claim”) for Indemnifiable Damages (but excluding
a claim for Indemnifiable Damages resulting from the assertion of liability by
third parties), it shall give written notice to the Indemnifying Party
specifying the nature and amount of the Indemnifiable Damages. If the
Indemnifying Party, within 30 business days after receipt of such Notice of
Claim by the Indemnified Party, has not given written notice (a “Notice of
Objection”) to the Indemnified Party announcing its intent to contest such
assertion by the Indemnified Party, such assertion shall be deemed accepted and
the amount of Indemnifiable Damages stated in the Notice of Claim shall be
deemed a valid claim therefor.

10.3    Procedure For Indemnification with
Respect to Third Party Claims.  If
any third party notifies the Indemnified Party with respect to any matter that
may give rise to a claim for indemnification against the Indemnifying Party
under this Article 10, then the Indemnified Party will notify the
Indemnifying Party thereof promptly and in any event within 30 days after
receiving any written notice from a third party; provided that no delay on the
part of the Indemnified Party in notifying the Indemnifying Party will relieve
the Indemnifying Party from any obligation hereunder unless, and then solely to
the extent that, the Indemnifying Party is prejudiced thereby.  Once the Indemnified Party has given notice
of the matter to the Indemnifying Party, the Indemnified Party may defend
against the matter in any manner it reasonably may deem appropriate.  In the event the Indemnifying Party notifies
the Indemnified Party within 30 days after the date the Indemnified Party has
given notice of the matter that the Indemnifying Party is assuming the defense
of such matter (a) the Indemnifying Party will defend the Indemnified
Party against the matter with counsel of its choice reasonably satisfactory to
the Indemnified Party, (b) the Indemnified Party may retain separate
counsel at its sole cost and expense (except that the Indemnifying Party will
be responsible for the fees and expenses of such separate co-counsel to the extent
the Indemnified Party

 

concludes in good
faith that the counsel the Indemnifying Party has selected has a conflict of
interest), (c) the Indemnified Party will not consent to the entry of a
judgment or enter into any settlement with respect to the matter, or take any
measure that imposes any burden or encumbrance upon the conduct of the
Indemnified Party or its operations, without the written consent of the
Indemnifying Party (not to be withheld or delayed unreasonably), (d) the
Indemnifying Party will not consent to the entry of a judgment with respect to
the matter or enter into any settlement that does not include a provision
whereby the plaintiff or claimant in the matter releases the Indemnified Party
from all liability with respect thereto, without the written consent of the
Indemnified Party (not to be withheld or delayed unreasonably), and (e) the
Indemnified Party shall have the right to attend, at its own expense, any
meetings relating to, and to receive upon request copies of all correspondence,
reports or other documents submitted or received by or on behalf of the
Indemnifying Party in connection with, the defense of such matter.

10.4    Survival of Representations and
Indemnification.  The Seller’s
obligation to pay Indemnifiable Damages and to comply with this Article 10
shall survive the Closing of this transaction for a period of five (5) years.

10.5    Limitation on Amount.  Seller will have no liability under Article
10.1 until the total of all Indemnifiable Damages exceeds FIFTY THOUSAND
DOLLARS ($50,000.00).  In no event will
Seller be liable for the Indemnifiable Damages of any nature on any one or more
claims under Article 10.1, which in the aggregate, exceed TWO MILLION FIVE
HUNDRED THOUSAND DOLLARS ($2,500,000.00), except that Indemnified Damages
arising directly or indirectly from a breach by Seller of the representations
made in Articles 4.4, 4.5, 4.6, 4.7(.1-.7), 4.8 and 4.9 shall not be subject to
such limitation.

10.6    Other Indemnification Provisions.  The foregoing indemnification provisions are
in addition to, and not in derogation of, any statutory, equitable, or common
law remedy the Buyer may have with respect to the Seller or pursuant to the
Prior Agreement, or the transactions contemplated by this Agreement; provided,
however, that the amount of any monetary changes shall be limited by Article
10.5.

10.7    Buyer’s Indemnification of Seller.  Notwithstanding the Closing, and regardless
of any investigation made by or on behalf of the Seller or any information
known to the Seller; the  Buyer, subject
to the terms and conditions of this Article 10.7, indemnifies and saves the
Seller, its shareholders, officers, directors and/or employees harmless from
and against any and all losses, claims, damages, actions, liabilities, costs,
expenses or deficiencies including, but not limited to, reasonable attorneys’
fees and other costs and expenses reasonably incident to proceedings or
investigations or the defense or settlement of any claim or claims, incurred by
or asserted against the Seller due to or resulting from any of the following:
(a) the inaccuracy or breach of any representation or warranty of the Buyer
given in or pursuant to this Agreement; (b) any breach or default in the
performance by the Buyer of any of its covenants, obligations or agreements in
or pursuant to this Agreement.  The
foregoing are collectively referred to as “Seller’s Indemnifiable Damages.”

10.7.1 Limitation
on Amount.  Buyer will have no
liability under Article 10.7 until the total of all Seller’s Indemnifiable
Damages exceeds FIFTY THOUSAND DOLLARS ($50,000.00).  In no event will Buyer be liable for the
Seller’s Indemnifiable Damages of any nature on any one or more claims under
Article 10.7, which in the aggregate, exceed TWO MILLION FIVE HUNDRED THOUSAND
DOLLARS ($2,500,000.00).

10.7.2 Procedure
for Indemnification.  The procedures
set forth in Articles 10.2 and 10.3 shall be operative, provided that for these
purposes the term “Indemnifiable Damages” shall be replaced with the term “Seller’s
Indemnifiable Damages”.

ARTICLE 11 – PRIOR AGREEMENTS

11.1 The
obligations of Seller and Buyer set forth in this Agreement shall be in
addition to and not in derogation of their obligations of the Prior Agreement.

ARTICLE 12 - DEFINITIONS

12.1    Certain Defined Terms.  As used in this Agreement, the following
terms shall have the meanings specified in this Article 12.1 unless the
context otherwise requires.  Any term
defined in the Prior Agreement that is not defined in this Agreement shall have
the meaning set forth in the Prior Agreement.

 

12.1.1      “Additional Patents” shall mean any and
all Other Patents having one or more claims that overlap in scope with any
claim of the Patents.

12.1.2      “Affiliate” shall mean any entity that is
now or hereafter becomes Controlled by, is in Control of, or is under common
Control with a Party.  “Control” shall
mean a fifty percent (50%) or more ownership of issued and outstanding voting
securities, or fifty percent (50%) or more of the voting rights in a
partnership or limited liability company, directly or indirectly.

12.1.3      “Agreement” means this Asset Purchase
Agreement, together with all Exhibits and Schedules hereto, as amended,
restated, supplemented or otherwise modified from time to time in accordance
with the terms hereof.

12.1.4      “Bill of Sale” means that Bill of Sale
Agreement, dated as of the Closing Date, between the Seller and the Buyer and
as set forth in Exhibit 6.5.1.

12.1.5      “Closing” has the meaning set forth in
Article 1.3.

12.1.6      “Closing Date” has the meaning set forth
in Article 1.3.

12.1.7      “Documentation” has the meaning set forth
in Article 1.2.

12.1.8      “Field” shall mean the design,
development, manufacture and use of video conferencing equipment and media
management procedures and technology.

12.1.9      “Governmental Authority” means the
government of the United States of America and any other country, and any
state, province, municipality or other governmental unit, or any agency, board,
bureau, instrumentality, department or commission (including any court or other
tribunal) of any of the foregoing.

12.1.10    “Indemnifiable Damages” has the meaning set
forth in Article 10.1.

12.1.11    “Knowledge” means, with respect to any
party, the actual knowledge of such party, its executive officers or its agents
after due inquiry; provided, however, that if such party fails to make such
inquiry, it shall include the constructive knowledge of such facts as would
have been learned had such due inquiry been made.

12.1.12    “Liability” means any liability or
obligation (whether known or unknown, whether asserted or unasserted, whether
absolute or contingent, whether accrued or unaccrued, whether liquidated or
unliquidated, and whether due or to become due).

12.1.13    “Lien” means any pledge, lien, encumbrance,
charge or other security interest of any kind.

12.1.14    “Notice of Claim” has the meaning set forth
in Article 10.2.

12.1.15    “Notice of Objection” has the meaning set
forth in Article 10.2.

12.1.16    “Other Patents” means the issued, unexpired
patents and applications for patents owned or controlled by Seller and not
assigned by this Agreement, and any foreign counterparts, reissues, extensions,
substitutions, confirmations, registrations, revalidations, additions, or
continuations, continuations-in-part, and divisions thereof in existence as of
the Closing Date.

12.1.17    “Patent Assignment” means that Patent
Assignment, dated as of the Closing Date, between the Seller and the Buyer and
as set forth in Exhibit 6.5.2.

12.1.18    “Patents” means the issued patents and
applications for patents set forth on Schedule 4.7.1 hereto, and any foreign
counterparts, reissues, extensions, substitutions, confirmations,
registrations, revalidations, additions, or continuations,
continuations-in-part, and divisions thereof in existence as of the Closing
Date.

 

12.1.19    “Purchase Price” has the meaning set forth
in Article 2.

12.1.20    “Purchased Assets” has the meaning set forth
in Article 1.2.

12.1.21   “Relevant Rights” shall mean all rights
existing under or hereafter accruing under any of the Patents or Other Patents,
specifically including but not limited to the right to claim infringement
thereof.

ARTICLE 13– MISCELLANEOUS

13.1    Survival of Representations and
Warranties.  All of the
representations and warranties and disclaimers thereof of the parties contained
in this Agreement shall survive the Closing hereunder for a period of three (3)
years. Covenants shall continue indefinitely unless limited by their own terms.

13.2    Benefit and Assignment.  This Agreement shall be binding upon and
inure to the benefit of the parties hereto, their heirs, successors, assignees,
and beneficiaries in interest; provided, however, that this Agreement may not
be assigned by either party without the prior written consent of the other
party, other than in connection with the sale of all or substantially all of
the assets of such party and, in the case of assignment by Buyer, Tandberg ASA.

13.3    Governing Law.  This Agreement shall be governed by and
construed in accordance with the internal laws of the State of  Delaware (regardless of such State’s conflict
of laws principles), and without reference to any rules of construction
regarding the party responsible for the drafting hereof.

13.4    Expenses.  Except as otherwise herein provided, all
expenses incurred in connection with this Agreement or the transactions herein
provided for shall be paid by the party incurring such expenses and costs.

13.5    Submission to Jurisdiction.  Each of the Buyer and the Seller submits to
the exclusive jurisdiction of any state or federal court sitting in Delaware in
any action or proceeding arising out of or relating to this Agreement and all
agreements and transactions contemplated hereby, and agrees that all claims in
respect of the action or proceeding may be heard and determined in any such
court.  Each of the Buyer and the Seller
also covenants and agrees not to bring any action or proceeding arising out of
or relating to this Agreement or any agreement or transaction contemplated
hereby in any other court.  Each of the
Buyer and the Seller waives any defense of inconvenient forum to the
maintenance of any action or proceeding so brought and waives any bond, surety,
or other security that might be required of any other party with respect
thereto.  Each party agrees that a final
judgment in any action or proceeding so brought shall be conclusive and may be
enforced by suit on the judgment or in any other manner provided by law or in
equity.

13.6    Notices.  Any and all notices, demands, and
communications provided for herein or made hereunder shall be given in writing
and shall be deemed given to a party at the earlier of (i) when hand delivered
to such party, (ii) when facsimile transmitted to such party to the facsimile
number indicated for such party below (or to such other facsimile number for a
party as such party may have substituted by notice pursuant to this
Article 13.6), or (iii) when received if sent by express courier,
confirmed by receipt, and addressed to such party at the address designated
below for such party (or to such other address for such party as such party may
have substituted by notice pursuant to this Article 13.6):

	
  If to the Buyer:

  	
  Tandberg Telecom
  AS

  
	
   

  	
  Philip Pedersens Vei 22

  
	
   

  	
  1366 Lysaker

  
	
   

  	
  NORWAY

  
	
   

  	
  Fax:
  011-47-67-125-234

  
	
   

  	
  Attention: President

  
	
   

  	
   

  
	
  With a copy to:

  	
  Oblon, Spivak,
  McClelland, Maier & Neustadt, P.C.

  
	
   

  	
  1940 Duke Street

  
	
   

  	
  Alexandria, Virginia 22314

  
	
   

  	
  Fax: 703-413-2220

  
	
   

  	
  Attention: Michael Monaco, Esq.

  

 

 

 

	
  If to the Seller:

  	
  Forgent
  Networks, Inc.

  
	
   

  	
  108 Wild Basin Road

  
	
   

  	
  Austin, Texas 78746

  
	
   

  	
  Fax: 512-437-2580

  
	
   

  	
  Attention: President

  

 

13.7    Counterparts.  This Agreement may be executed simultaneously
in two or more counterparts, each of which shall be deemed an original, but all
of which together shall constitute one and the same instrument, provided that
all such counterparts, in the aggregate, shall contain the signatures of all
parties hereto.

13.8    Headings.  All Article headings herein are inserted
for convenience only and shall not modify or affect the construction or
interpretation of any provision of this Agreement.

13.9    Amendment, Modification and Waiver.  This Agreement may not be modified, amended
or supplemented except by mutual written agreement of all the parties
hereto.  Any party may waive in writing
any term or condition contained in this Agreement and intended to be for its
benefit; provided, however, that no waiver by any party, whether by conduct or
otherwise, in any one or more instances, shall be deemed or construed as a
further or continuing waiver of any such term or condition.  Each amendment, modification, supplement or
waiver shall be in writing signed by the party or the parties to be charged.

13.10  Entire Agreement.  This Agreement and the Exhibits and Schedules
attached hereto represent the full and complete agreement of the parties with
respect to the subject matter hereof and supersede and replace any prior
understandings and agreements among the parties with respect to the subject
matter hereof and no provision or document of any kind shall be included in or
form a part of such agreement unless signed and delivered to the other party by
the parties to be charged.

13.11  Third-Party Beneficiaries.  No third parties are intended to benefit from
this Agreement, and no third-party beneficiary rights shall be implied from anything
contained in this Agreement.

13.12  Publicity.  The Buyer and the Seller shall cooperate in
making appropriate additional public announcements concerning the terms of this
Agreement and the transactions contemplated hereby and shall not do so independently,
except that each Party shall unilaterally have the authority to make such
statements upon advanced notice to the other Party to the extent it reasonably
decides such disclosure is required in order to comply with the laws or stock
exchange rules of any country.

13.13  Intepretation.  Each of the Parties have been represented by
counsel and has had the opportunity to negotiate, review, revise and comment on
the terms set forth herein.  As a result,
the Parties acknowledge and agree that in interpreting the provisions of this
contract no weight shall be given to which Party drafted or revised any
provision of this Agreement, each provision considered to have been the joint
work product of both Parties.

13.14  Disclosure Schedules.  The disclosure of information on any
disclosure schedule shall be deemed to constitute disclosure of such
information on any other schedules hereto to which such information may relate
and shall qualify all of the representations and warranties contained herein
that are relevant thereto.

IN
WITNESS WHEREOF, the parties hereto have caused this
Agreement to be executed as of the date and year first above written.

	
  

  	
  FORGENT NETWORKS, INC.

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  /s/ RICHARD N.
  SNYDER

  
	
   

  	
  By:

  	
  Richard Snyder

  
	
   

  	
  Title:

  	
  Chairman and CEO

  
	
   

  	
   

  	
   

  
	
   

  	
  TANDBERG TELECOM AS

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  /s/ PER H.
  KOGSTAD

  
	
   

  	
  By:

  	
  Per H. Kogstad

  
	
   

  	
  Title:

  	
  President

  

 

 

SCHEDULE
3

ASSUMED
LIABILITIES

None.

 

SCHEDULE
4.5

TITLE
ISSUES

None.

 

SCHEDULE
4.6

REQUIRED
THIRD PARTY CONSENTS

None.

 

CONFIDENTIAL:
Subject to Attorney-Client Privilege

Schedule
4.7.1.1 – Patents Assigned

	
  Patent

  Number

  	
   

  	
  Filing

  date

  	
   

  	
  Issue

  date

  	
   

  	
  Title

  
	
  5,657,246

  	
   

  	
  3/7/1995

  	
   

  	
  8/12/1997

  	
   

  	
  Method and apparatus for a video conference user
  interface

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  5,768,263

  	
   

  	
  10/20/1995

  	
   

  	
  6/16/1998

  	
   

  	
  Method for talk/listen determination and multipoint
  conferencing system using such method

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  5,825,754

  	
   

  	
  12/28/1995

  	
   

  	
  10/20/1998

  	
   

  	
  Filter and process for reducing noise in audio
  signals

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  5,872,922

  	
   

  	
  8/8/1997

  	
   

  	
  2/16/1999

  	
   

  	
  Method and apparatus for a video conference user
  interface

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  5,920,356

  	
   

  	
  6/6/1996

  	
   

  	
  7/6/1999

  	
   

  	
  Coding parameter adaptive transform artifact
  reduction process

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  5,933,597

  	
   

  	
  4/4/1996

  	
   

  	
  8/3/1999

  	
   

  	
  Method and system for sharing objects between local
  and remote terminals

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  5,959,667

  	
   

  	
  5/9/1996

  	
   

  	
  9/28/1999

  	
   

  	
  Voice activated camera preset selection system and
  method of operation

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  5,991,277

  	
   

  	
  4/9/1998

  	
   

  	
  11/23/1999

  	
   

  	
  Primary transmission site switching in a multipoint
  videoconference environment based on human voice

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  6,178,205

  	
   

  	
  12/12/1997

  	
   

  	
  1/23/2001

  	
   

  	
  Video postfiltering with motion-compensated temporal
  filtering and/or spatial-adaptive filtering

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  6,192,342

  	
   

  	
  11/17/1998

  	
   

  	
  2/20/2001

  	
   

  	
  Automated camera aiming for identified talkers

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  6,285,405

  	
   

  	
  10/14/1998

  	
   

  	
  9/4/2001

  	
   

  	
  System and method for synchronizing data signals

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  6,476,873

  	
   

  	
  10/23/1998

  	
   

  	
  11/5/2002

  	
   

  	
  Enhancement of a selectable region of video

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  6,590,603

  	
   

  	
  10/31/2001

  	
   

  	
  7/8/2003

  	
   

  	
  System and method for managing streaming data

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  6,707,489

  	
   

  	
  12/8/1998

  	
   

  	
  3/16/2004

  	
   

  	
  Automatic voice tracking camera system and method of
  operation

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  6,731,334

  	
   

  	
  7/31/1995

  	
   

  	
  5/4/2004

  	
   

  	
  Automatic voice tracking camera system and method of
  operation

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  6,968,064

  	
   

  	
  9/28/2001

  	
   

  	
  11/22/2005

  	
   

  	
  Adaptive thresholds in acoustic echo canceller for
  use during double talk

  

 

 

CONFIDENTIAL:
Subject to Attorney-Client Privilege

Schedule 4.7.1.2 – Patent Applications Assigned

	
  App. Ser. No

  Publication No.

  	
   

  	
  Filing Date

  	
   

  	
  Title

  
	
  11/124,772

  2005/0207567

  	
   

  	
  5/9/2005

  	
   

  	
  Communications System and Method Utilizing
  Centralized Signal Processing

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  11/129,962

  2005/0210393

  	
   

  	
  5/16/2005

  	
   

  	
  Asynchronous Collaboration via Audio/Video
  Annotation

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  09/627,731

  unpublished

  	
   

  	
  7/28/2000

  	
   

  	
  System and Method for Generating Invisible Notes on
  a Presenter’s Screen

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  11/243,236

  2006/0034448

  	
   

  	
  10/4/2005

  	
   

  	
  Distortion Compensation in an Acoustic Echo Canceler

  
	
   

  	
   

  	
   

  	
   

  	
   

  
	
  09/845,947

  2002/0062403

  	
   

  	
  4/30/2001

  	
   

  	
  Method and System for Creation of Virtual Events

  

 

 

SCHEDULE 4.7.5

INFRINGEMENT NOTICES SENT

None.

 

 

Schedule 4.8

 

	
  Party

  	
   

  	
  License to

  Patent #

  	
   

  	
  Covenant Not To

  Assert

  	
   

  	
  Expiration of

  C.N.A.

  	
   

  	
  Transferrable /

  Assignable

  	
   

  	
  Sub-

  Licensable

  
	
  1.)

  	
  Polycom

  	
   

  	
  5,959,667

  	
   

  	
  None

  	
   

  	
  N/A

  	
   

  	
  No

  	
   

  	
  No

  
	
  

  	
   

  	
   

  	
  5,825,754

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  2.)

  	
  Large Computer

  	
   

  	
  None on list

  	
   

  	
  Yes

  	
   

  	
  July, 2008

  	
   

  	
  No

  	
   

  	
  No

  
	
   

  	
  Manufacturer

  	
   

  	
   

  	
   

  	
  All owned patents

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  3.)

  	
  VTEL Products Group

  	
   

  	
  Patents

  	
   

  	
  None

  	
   

  	
  N/A

  	
   

  	
  Yes. One time for the sale of 

  all/substantially 

  all of the

  assets of the 

  company.

  	
   

  	
  No

  
	
   

  	
   

  	
   

  	
  5,657,246

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
  

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
  5,768,263

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  5,825,754

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  5,972,922

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  5,920,356

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  5,933,597

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  5,959,667

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  5,991,277

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  6,178,205

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  6,192,342 B1

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  6,285,405

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  6,476,873

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  6,731,334

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  Applications

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  09/609,609

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  09/627,731

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  09/660,205

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00114-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00114-of-00352.parquet"}]]